S100A4, OPN and ephrin-A1 are all potentially interesting biomarkers that may have clinical impact in NSCLC, and in this follow-up study we investigate the association between the expression of these proteins and patient outcome in the previously described cohort. Here, SPP1 is linked to non-small cell lung carcinoma.